Replies to post #514930 on NorthWest Biotherapeutics Inc (NWBO)

[vator]

Not necessarily so. Advent is the manufacturing arm. And NWBO owns Flasworks. As far as development of assets- all they need is cash. Partnership can gain a sales force and pushing other indications. Or just selling Cs outright. The preferred C shares are there for a reason. To generate cash with or without a partner. I think a partner.

[GoodGuyBill]

$7 for the DCVax-L platform (+ world-wide manufacturing + automation) can be reasonably seen as pessimistic, imo.

[georgebailey]

Re valuation- there’s been a quiet period for 2 years, no JA describing Phase 3 and little info on combo therapies has been made public. Good luck with valuations. If the preferred C gets issued to a BP or financial strategic there we go- they have NDA’s.